Literature DB >> 9636148

Effective inhibition of influenza virus production in cultured cells by external guide sequences and ribonuclease P.

D Plehn-Dujowich1, S Altman.   

Abstract

The polymerase (PB2) and nucleocapsid (NP) genes encoded by the genome of influenza virus are essential for replication of the virus. When synthetic genes that express RNAs for external guide sequences targeted to the mRNAs of the PB2 and NP genes are stably incorporated into mouse cells in tissue culture, infection of these cells with influenza virus is nonproductive. Endogenous RNase P cleaves the targeted influenza virus mRNAs when they are in a complex with the external guide sequences. Targeting two different mRNAs simultaneously inhibits viral particle production more efficiently than does targeting only one mRNA.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9636148      PMCID: PMC22606          DOI: 10.1073/pnas.95.13.7327

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  Roles of the influenza virus polymerase and nucleoprotein in forming a functional RNP structure.

Authors:  K Klumpp; R W Ruigrok; F Baudin
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

2.  Phenotypic conversion of drug-resistant bacteria to drug sensitivity.

Authors:  C Guerrier-Takada; R Salavati; S Altman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

Review 3.  Anti-gene therapy: the use of ribozymes to inhibit gene function.

Authors:  L A Couture; D T Stinchcomb
Journal:  Trends Genet       Date:  1996-12       Impact factor: 11.639

4.  Complete nucleotide sequence of the nucleoprotein gene from the human influenza strain A/PR/8/34 (HON1).

Authors:  L Van Rompuy; W Min Jou; D Huylebroeck; R Devos; W Fiers
Journal:  Eur J Biochem       Date:  1981-05-15

5.  Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus.

Authors:  R Mann; R C Mulligan; D Baltimore
Journal:  Cell       Date:  1983-05       Impact factor: 41.582

Review 6.  Anti-HIV ribozymes.

Authors:  L Q Sun; J A Ely; W Gerlach; G Symonds
Journal:  Mol Biotechnol       Date:  1997-06       Impact factor: 2.860

7.  Complete nucleotide sequence of the polymerase 3 gene of human influenza virus A/WSN/33.

Authors:  J S Kaptein; D P Nayak
Journal:  J Virol       Date:  1982-04       Impact factor: 5.103

8.  Role of two of the influenza virus core P proteins in recognizing cap 1 structures (m7GpppNm) on RNAs and in initiating viral RNA transcription.

Authors:  I Ulmanen; B A Broni; R M Krug
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

9.  Structure in solution of M1 RNA, the catalytic subunit of ribonuclease P from Escherichia coli.

Authors:  C Guerrier-Takada; S Altman
Journal:  Biochemistry       Date:  1984-12-18       Impact factor: 3.162

10.  Influenza virus temperature-sensitive cap (m7GpppNm)-dependent endonuclease.

Authors:  I Ulmanen; B Broni; R M Krug
Journal:  J Virol       Date:  1983-01       Impact factor: 5.103

View more
  38 in total

1.  Effective inhibition of human cytomegalovirus gene expression and replication by a ribozyme derived from the catalytic RNA subunit of RNase P from Escherichia coli.

Authors:  P Trang; M Lee; E Nepomuceno; J Kim; H Zhu; F Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

2.  RNA-protein hybrid ribozymes that efficiently cleave any mRNA independently of the structure of the target RNA.

Authors:  M Warashina; T Kuwabara; Y Kato; M Sano; K Taira
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

3.  Coordinate inhibition of expression of several genes for protein subunits of human nuclear RNase P.

Authors:  Elizaveta Kovrigina; Donna Wesolowski; Sidney Altman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-27       Impact factor: 11.205

4.  Inhibition of no tail (ntl) gene expression in zebrafish by external guide sequence (EGS) technique.

Authors:  De-Sheng Pei; Yong-Hua Sun; Yong Long; Zuo-Yan Zhu
Journal:  Mol Biol Rep       Date:  2007-02-09       Impact factor: 2.316

Review 5.  Inhibition of gene expression in human cells using RNase P-derived ribozymes and external guide sequences.

Authors:  Kihoon Kim; Fenyong Liu
Journal:  Biochim Biophys Acta       Date:  2007-09-29

6.  Rapid selection of accessible and cleavable sites in RNA by Escherichia coli RNase P and random external guide sequences.

Authors:  Eirik W Lundblad; Gaoping Xiao; Jae-Hyeong Ko; Sidney Altman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-08       Impact factor: 11.205

7.  Effective inhibition in animals of viral pathogenesis by a ribozyme derived from RNase P catalytic RNA.

Authors:  Yong Bai; Phong Trang; Hongjian Li; Kihoon Kim; Tianhong Zhou; Fenyong Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-28       Impact factor: 11.205

8.  Effective inhibition of HCMV UL49 gene expression and viral replication by oligonucleotide external guide sequences and RNase P.

Authors:  WenJun Zhang; HongJian Li; YueQin Li; ZhiFeng Zeng; ShiQian Li; Xin Zhang; Yi Zou; TianHong Zhou
Journal:  Virol J       Date:  2010-05-18       Impact factor: 4.099

9.  Generation of an external guide sequence library for a reverse genetic screen in Caenorhabditis elegans.

Authors:  Qitao Yan; Rui Zhao; Wenlin Zheng; Changxin Yin; Bao Zhang; Wenli Ma
Journal:  BMC Biotechnol       Date:  2009-05-20       Impact factor: 2.563

10.  Gene silencing in the therapy of influenza and other respiratory diseases: Targeting to RNase P by use of External Guide Sequences (EGS).

Authors:  David H Dreyfus; S Mark Tompkins; Ramsay Fuleihan; Lucy Y Ghoda
Journal:  Biologics       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.